PI: Canivell Fusté, Silvia. Caracterización del riesgo fracturario en pacientes diabéticos mayores de 50 años tratados con SGLT2 inhibidores. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2021

PI: Mauricio Puente, Dídac. All-cause and cardio-renal-metabolic mortality in people with type 2 diabetes: a comparative international trend study. Funding: University of Leicester. Duration: 2019 - 2021

PI: López Simarro, Flora. INercia y adherencia al TratamiENto antidiabético entre los pacientes atendidos en los centroS de atención primaria en España: Estudio INTENSE.  Duration: 2019 - 2021

PI: Mauricio Puente, Dídac. Descubrimiento y validación de marcadores de predicción de diabetes tipo 2: proyecto colaborativo de cohortes. Funding: IDIAP Jordi Gol. Duration: 2019 - 2021

PI: Canivell Fusté, Silvia. Influencia del tratamiento antidiabético en el desarrollo de deterioro cognitivo en los pacientes diabéticos tipo 2 en Barcelona. Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2021

PI: Aguado Jodar, Alba. Xarxes de multimorbiditat , prescripció farmacèutica i factors de risc de la població adulta catalana. Estudi MorbiNet. Funding: Consorci Sanitari Integral. Duration: 2018 - 2020

PI: Franch Nadal, Josep. Estudio sobre los resultados de la adición de una sulfonilurea, un iDPP4 o un iSGLT2 como segundo antidiabético en pacientes con DM2 en tratamiento con metformina e insuficiente control glucémico. Estudio eControl Metf+. Funding: AstraZeneca Farmacéutica Spain, S.A. Duration: 2018 - 2020

PI: Olona Tabueña, Noemí. Predicció del risc cardiovascular mitjançant escales en pacients amb transtorn mental sever: estudi de cohorts retorspectiu. Funding: IDIAP Jordi Gol. Duration: 2018 - 2020

PI: Mata Cases, José Manuel. Inercia terapéutica en los pacientes con Diabetes tipo 2 tratados con dos o más antidiabéticos no insulínicos seguidos durante 7 años en un registro poblacional. Duration: 2019

PI: Orfila Pernas, Francesc. Evaluación e intervención multimodal centrada en el paciente anciano en riesgo de resultados adversos, fragilidad y declive funcional en la comunidad. Proyecto CARTS. Funding: Instituto de Salud Carlos III. Duration: 2017 - 2019

PI: Fernández San Martin, Maria Isabel. Efectividad de una intervención grupal psicoeducativa realizada por enfermeras de Atención Primaria en pacientes con depresión y comorbilidad física. Funding: Instituto de Salud Carlos III. Duration: 2017 - 2019

PI: Moreno Martínez, José Antonio. Asociación de diabetes y tuberculosis en un distrito con alta incidencia de tuberculosis. Estudio de casos y controles, 2007-2016. Funding: Instituto de Salud Carlos III. Duration: 2017 - 2019

PI: Mauricio Puente, Dídac. Estudio sobre la adecuación del uso de agonistas del receptor del GLP1 en personas con DM2 en condiciones reales en la Atención Primaria de Cataluña. Estudi CATALONIA. Funding: GlaxoSmithKline, S.A.. Duration: 2017 - 2019

PI: Mata Cases, José Manuel. Caracterización del riesgo cardiovascular antes del primer evento cardiovascular a una edad prematura en Cataluña. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019

PI: Mata Cases, José Manuel. Caracterización del riesgo cardiovascular antes del primer evento cardiovascular prematuro en Catalunya. Funding: Departament de Salut. Duration: 2017 - 2019

PI: Franch Nadal, Josep. Incidència de la diabetis tipus 2 a Catalunya (estudi di@bet.es II .cat). Funding: Departament de Salut. Duration: 2017 - 2019

PI: Franch Nadal, Josep. Patient characteristics and cardiovascular and mortality outcomes in patients with high cardiovascular risk and type 2 diabetes mellitus initiating treatment with sodium-glucose co-transporter-2 inhibitors and other antidiabetic medications. Funding: AstraZeneca Farmacéutica Spain, S.A.. Duration: 2017 - 2019

PI: Mata Cases, José Manuel. Global and country-specific rates and trends in the incidence of diagnosed type 2 diabetes (GLOBALDIAB). Funding: . Duration: 2017 - 2019

PI: Verdú Rotellar, José María. Estratificación pronóstica de la insuficiencia cardiaca descompensada en atención primaria: Estudio HEFESTOS. Funding: Instituto de Salud Carlos III. Duration: 2015 - 2019

Boswell L, Jiménez A, Ortega E, Pané A, Hollanda A, Moizé V, Andreu A, Ibarzabal A, Flores L, Vidal J. Genetic background influences weight-loss trajectories on the mid-term after bariatric surgery. Int J Obes (Lond). 2019 09; 43(9):1869-1874. doi:10.1038/s41366-018-0229-4. Epub 2018 Oct 09. PMID:30301966. IF: 4,514.

Canivell S, Mata-Cases M, Real J, Franch-Nadal J, Vlacho B, Khunti K, Gratacòs M, Mauricio D. Glycemic Control after Treatment Intensification in Patients with Type 2 Diabetes Uncontrolled on Two or More Non-Insulin Antidiabetic Drugs in a Real-World Setting. Diabetes Obes Metab. 2019 Feb; doi:10.1111/dom.13663. Epub 2019 Feb 12. PMID:30756446. IF: 6,133.

Canivell S, Mata-Cases M, Vlacho B, Gratacòs M, Real J, Mauricio D, Franch-Nadal J. How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area. J Diabetes Res. 2019 ; 2019:2018374. doi:10.1155/2019/2018374. Epub 2019 Nov 11. pmc:PMC6877986. PMID:31815146. IF: 3,040.

Casañas R, Martín Royo J, Fernandez-San-Martín MI, Raya Tena A, Mendioroz J, Sauch Valmaña G, Masa-Font R, Casajuana-Closas M, Fernandez Linares EM, Cols-Sagarra C, Gonzalez Tejón S, Foguet-Boreu Q, Martín Lopez LM. Effectiveness of a psychoeducation group intervention conducted by primary healthcare nurses in patients with depression and physical comorbidity: study protocol for a randomized, controlled trial. BMC Health Serv Res. 2019 Jun; 19(1):427. doi:10.1186/s12913-019-4198-7. Epub 2019 Jun 26. PMID:31242892. IF: 1,932.

Castelblanco E, Betriu À, Hernández M, Granado-Casas M, Ortega E, Soldevila B, Ramírez-Morros A, Franch-Nadal J, Puig-Domingo M, Fernández E, Avogaro A, Alonso N, Mauricio D. Ultrasound Tissue Characterization of Carotid Plaques Differs Between Patients with Type 1 Diabetes and Subjects without Diabetes. J Clin Med. 2019 Mar; 8(4). doi:10.3390/jcm8040424. Epub 2019 Mar 28. pmc:PMC6518191. PMID:30925670. IF: 5,688.

Castelblanco E, Sanjurjo L, Falguera M, Hernández M, Fernandez-Real JM, Sarrias MR, Alonso N, Mauricio D. Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects. J Clin Med. 2019 May; 8(5). doi:10.3390/jcm8050710. Epub 2019 May 18. pmc:PMC6571689. PMID:31109109. IF: 5,688.

Ezquerra-Lázaro I, Cea-Soriano L, Giraldez-García C, Ruiz A, Franch-Nadal J, Diez-Espino J, Nogales P, Carramiñana F, Javier Sangros F, Regidor E; PREDAPS Study Group. Lifestyle factors do not explain the difference on diabetes progression according to type of prediabetes: Results from a Spanish prospective cohort of prediabetic patients. Diabetes Res. Clin. Pract. 2019 Jul; 153:66-75. doi:10.1016/j.diabres.2019.05.033. Epub 2019 May 29. PMID:31152806. IF: 3,239.

Franch-Nadal J, Mata-Cases M, Ortega E, Real J, Gratacòs M, Vlacho B, Vallés JA, Mauricio D. Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia. J Clin Med. 2019 Sep; 8(9). doi:10.3390/jcm8091389. Epub 2019 Sep 05. pmc:PMC6780172. PMID:31491916. IF: 5,688.

Gómez García MC, Millaruelo Trillo JM, Avila Lachica L, Cos-Claramunt FX, Franch-Nadal J, Cortés Gil X. [ESCRYTO study. Diabetes without cardiovascular disease and level of control]. Semergen. 2019 Dec; doi:10.1016/j.semerg.2019.11.006. Epub 2019 Dec 21. Spanish. PMID:31874786.

González-Marrón A, Real J, Forné C, Roso-Llorach A, Navarrete-Muñoz EM, Martínez-Sánchez JM. Confidence interval reporting for measures of association in multivariable regression models in observational studies. Med Clin (Barc). 2019 Sep 27;153(6):239-242. doi: 10.1016/j.medcli.2018.06.018. Epub 2018 Aug 25. English, Spanish. PubMed PMID: 30154010. IF: 1,277.

Granado-Casas M, Alcubierre N, Martín M, Real J, Ramírez-Morros AM, Cuadrado M, Alonso N, Falguera M, Hernández M, Aguilera E, Lecube A, Castelblanco E, Puig-Domingo M, Mauricio D. Improved adherence to Mediterranean Diet in adults with type 1 diabetes mellitus. Eur J Nutr. 2019 Sep;58(6):2271-2279. doi: 10.1007/s00394-018-1777-z. Epub 2018 Jul 17. PubMed PMID: 30019088; PubMed Central PMCID: PMC6689285. IF: 4,449.

Granado-Casas M, Castelblanco E, Ramírez-Morros A, Martín M, Alcubierre N, Martínez-Alonso M, Valldeperas X, Traveset A, Rubinat E, Lucas-Martin A, Hernández M, Alonso N, Mauricio D. Poorer Quality of Life and Treatment Satisfaction is Associated with Diabetic Retinopathy in Patients with Type 1 Diabetes without Other Advanced Late Complications. J Clin Med. 2019 Mar; 8(3). doi:10.3390/jcm8030377. Epub 2019 Mar 18. pmc:PMC6462963. PMID:30889868. IF: 5,688.

Jiménez A, Ibarzabal A, Moizé V, Pané A, Andreu A, Molero J, de Hollanda A, Flores L, Ortega E, Lacy A, Vidal J. Ten-year outcomes after Roux-en-Y gastric bypass and sleeve gastrectomy: an observational nonrandomized cohort study. Surg Obes Relat Dis. 2019 Mar; 15(3):382-388. doi:10.1016/j.soard.2019.01.020. Epub 2019 Jan 29. PMID:30772254. IF: 3,758.

Jiménez-Balado J, Riba-Llena I, Abril O, Garde E, Penalba A, Ostos E, Maisterra O, Montaner J, Noviembre M, Mundet X, Ventura O, Pizarro J, Delgado P. Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension. Hypertension. 2019 Feb; 73(2):342-349. doi:10.1161/HYPERTENSIONAHA.118.12090. PMID:30606062. IF: 7,017.

Lago-Sampedro A, García-Escobar E, Rubio-Martín E, Pascual-Aguirre N, Valdés S, Soriguer F, Goday A, Calle-Pascual A, Castell C, Menéndez E, Delgado E, Bordiú E, Castaño L, Franch-Nadal J, Girbés J, Chaves FJ, Gaztambide S, Rojo-Martínez G, Olveira G. Dairy Product Consumption and Metabolic Diseases in the Di@bet.es Study. Nutrients. 2019 Jan; 11(2). doi:10.3390/nu11020262. Epub 2019 Jan 24. pmc:PMC6412325. PMID:30682848. IF: 4,171.

Mata-Cases M, Franch-Nadal J, Ortega E, Real J, Gratacòs M, Vlacho B, Mauricio D. Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: real-world evidence from a Mediterranean area. Curr Med Res Opin. 2019 May; doi:10.1080/03007995.2019.1618806. Epub 2019 May 13. PMID:31081693. IF: 2,345.

Mata-Cases M, Franch-Nadal J, Real J, Cedenilla M, Mauricio D. Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study. BMJ Open. 2019 Oct; 9(10):e031281. doi:10.1136/bmjopen-2019-031281. Epub 2019 Oct 28. PMID:31662386. IF: 2,376.

Meneghini LF, Mauricio D, Orsi E, Lalic NM, Cali AMG, Westerbacka J, Stella P, Candelas Dea C, Pilorget V, Perfetti R, Khunti K; DUNE investigators. The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting. Diabetes Obes Metab. 2019 Jun; 21(6):1429-1436. doi:10.1111/dom.13673. Epub 2019 Mar 28. pmc:PMC6593824. PMID:30768845. IF: 6,133.

Miquel E, Esquerda M, Real J, Espejo M, Pifarré J. Design and Validation of an Instrument To Measure a Minor's Maturity When Faced with Health Decisions. J Bioeth Inq. 2019 Aug; doi:10.1007/s11673-019-09930-4. Epub 2019 Aug 01. PMID:31372885. IF: 1,592.

Molló À, Berenguera A, Rubinat E, Vlacho B, Mata M, Franch J, Bolíbar B, Mauricio D. INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control. BMC Fam Pract. 2019 02; 20(1):25. doi:10.1186/s12875-019-0916-9. Epub 2019 Feb 07. pmc:PMC6367799. PMID:30732583. IF: 2,431.

Palanca A, Castelblanco E, Betriu À, Perpiñán H, Soldevila B, Valdivielso JM, Bermúdez-Lopez M, Puig-Jové C, Puig-Domingo M, Groop PH, Fernández E, Alonso N, Mauricio D. Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease. Cardiovasc Diabetol. 2019 Jul; 18(1):93. doi:10.1186/s12933-019-0897-y. Epub 2019 Jul 19. pmc:PMC6639953. PMID:31324183. IF: 5,948.

Polonsky WH, Fisher L, Hessler D, Stuckey H, Snoek FJ, Tang T, Hermanns N, Mundet X, Silva M, Sturt J, Okazaki K, Hadjiyianni I, Cao D, Ivanova J, Desai U, Perez-Nieves M. Identifying solutions to psychological insulin resistance: An international study. J. Diabetes Complicat. 2019 Apr; 33(4):307-314. doi:10.1016/j.jdiacomp.2019.01.001. Epub 2019 Jan 17. PMID:30709604. IF: 2,684.

Rodríguez-Fortúnez P, Franch-Nadal J, Fornos-Pérez JA, Martínez-Martínez F, de Paz HD, Orera-Peña ML. Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient's perspective. The EnREDa2 Study. BMJ Open. 2019 Jun; 9(6):e028467. doi:10.1136/bmjopen-2018-028467. Epub 2019 Jun 22. pmc:PMC6596977. PMID:31230025. IF: 2,376.

Rodríguez-Poncelas A, Franch-Nadal J, Coll-de Tuero G, Mata-Cases M, Alonso-Fernández M, Mur-Marti T, Ruiz A, Giraldez-García C, Regidor E. High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study. PLoS ONE. 2019 ; 14(9):e0222848. doi:10.1371/journal.pone.0222848. Epub 2019 Sep 19. PMID:31536578. IF: 2,776.

Valdés S, Doulatram Gamgaram VK, Lago A, García-Torres F, Badia-Guillen R, Olveira G, Goday A, Calle-Pascual A, Castaño L, Castell C, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbés J, Gomis R, Ortega E, Galan-Garcia JL, Aguilera-Venegas G, Soriguer F, Rojo-Martínez G. Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population. Di@bet.es study. Eur. J. Endocrinol. 2019 Mar; doi:10.1530/EJE-18-0818. Epub 2019 Mar 01. PMID:30840583. IF: 5,107.

Researchers with PhD

8

Total number of projects in which group members have participated

21

Total number of projects in which the PI of the project has belonged to the group

13

Total Funding

710.854,62€

Scientific publications in indexed journals

24

Total Impact factor

96,05

Nº of articles in Q1 journals

13

Q1 IF

69,982

Nº of articles in Q2 journals

8

Q2 IF

20,175